Bridgeway Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50,000	Closed	-$88K	–	1330
2024 Q3	$88K	Buy	+50,000	New	+$69.8K	﹤0.01%	1169
2020 Q2	–	Sell	-69,650	Closed	-$566K	–	1415
2020 Q1	$566K	Sell	69,650 -23,950	-26%	-$207K	0.01%	727
2019 Q4	$809K	Buy	93,600 +50,000	+115%	+$281K	0.01%	797
2019 Q3	$269K	Sell	43,600 -2,800	-6%	-$22.6K	﹤0.01%	1117
2019 Q2	$770K	Buy	46,400 +12,500	+37%	+$217K	0.01%	824
2019 Q1	$567K	Buy	33,900 +15,973	+89%	+$230K	0.01%	994
2018 Q4	$206K	Sell	17,927 -10,000	-36%	-$202K	﹤0.01%	1214
2018 Q3	$1.12M	Buy	27,927 +13,525	+94%	+$385K	0.01%	840
2018 Q2	$407K	Buy	+14,402	New	+$319K	﹤0.01%	1193
2017 Q2	–	Sell	-7,500	Closed	-$53K	–	1483
2017 Q1	$53K	Hold	7,500	–	–	﹤0.01%	1361
2016 Q4	$30K	Hold	7,500	–	–	﹤0.01%	1391
2016 Q3	$55K	Sell	7,500 -11,375	-60%	-$76.9K	﹤0.01%	1400
2016 Q2	$96K	Buy	18,875 +6,250	+50%	+$115K	﹤0.01%	1384
2016 Q1	$272K	Hold	12,625	–	–	﹤0.01%	1235
2015 Q4	$386K	Buy	12,625 +2,000	+19%	+$58.7K	0.01%	1141
2015 Q3	$354K	Buy	10,625 +3,125	+42%	+$176K	0.01%	1169
2015 Q2	$348K	Buy	+7,500	New	+$280K	0.01%	1206